The use of tissue microarray methodologies has increased dramatically over the past decade. Now, the National Cancer Institute and The Netherlands Cancer Institute have become the first research organisations to adopt TMALab II software.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.